Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic evaluation of a new BeneFIX formulation in Italian patients with hemophilia B
2008-006465-85Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of coagulation factor ix recombinant in hemophilia B (HB), sponsored by Azienda Ospedaliero-Universitaria Careggi. Primary endpoint: Primary pharmacokinetic endpoints. Started Mar 2009; status: active.
02
Drugs
coagulation factor ix recombinant
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on 2008-006465-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006465-85.